Search

Your search keyword '"O. V. Golovanova"' showing total 45 results

Search Constraints

Start Over You searched for: Author "O. V. Golovanova" Remove constraint Author: "O. V. Golovanova"
45 results on '"O. V. Golovanova"'

Search Results

1. Early chronic venous disease. What should be done?

2. PROMOTOR POLYMORPHISM OF IL-4, IL-6, AND IL-10 GENES AMONG PATIENTS WITH BREAST CANCER

3. PROMOTER POLYMORPHISM OF IL-1β GENE IN PATIENTS WITH A HISTORY OF ACUTE MYOCARDIAL INFARCTION

4. COMBINATION ANALYSIS OF CYTOKINE GENE PROMOTER POLYMORPHISMS OF IL1B T-31C, IL-6 G-174C, TNFA G-238A, TNFA G-308A, TNFA C-863A, IL4 C-590T, IL-10 C-592A FOR PREDICTION OF TREATMENT EFFICIENCY IN RHEUMATOID ARTHRITIS

5. ASSOCIATION OF LETHAL OUTCOMES IN SURGICAL SEPSIS WITH ALLELIC VARIANTS OF TNF Α AND HEAT SHOCK PROTEIN (HSP70-2) GENES

6. VEGFA GENE POLYMORPHISM (С-2578A, C+936T) IN PATIENTS WITH BREAST CANCER

7. ANALYSIS OF CORRELATION BETWEEN IL 6 GENE POLYMORPHISM (-174 G /C) AND CLASSIC RISK FACTORS IN PATIENTS WITH PREVIOUS MYOCARDIAL INFARCTIONS

8. FEATURES OF HSP70-2 AND HSP70-НОМ GENE POLYMORPHISM IN THE PATIENTS WITH A HISTORY OF MYOCARDIAL INFARCTION

11. KOMPLEKSNYY ANALIZ KLINIChESKOY ZNAChIMOSTI VYYaVLENIYaALLEL'NYKh VARIANTOV GENOV TsITOKINOV IL1B, IL6, IL10, TNFA IFAKTORA ROSTA VEGF V KAChESTVE GENETIChESKIKh FAKTOROV RISKARAZVITIYa OSTEOPOROZA PRI SAKhARNOM DIABETE 2 TIPA

12. Pharmacogenetic criteria for the efficacy of basic anti-inflammatory therapy for rheumatoid arthritis

13. Analysis of the gene polymorphism of matrix metalloproteinase-2 and -9 in patients with coronary heart disease

14. Cretaceous-Paleogene (K/T) boundary in the North-Eastern Caucasus (Dagestan): sedimentology, geochemistry and biota

15. Cretaceous–Paleogene Boundary in the Sequences of the Northeastern Caucasus, Dagestan: Sedimentology, Geochemistry, and Biota

16. Significance of the Sedimentary Water Integrity of the Neo-Pleistocene Aquifer System in the Northern Near-Caspian Region for the Development of the Caspian Sedimentary Basin

17. Lithological and Geochemical Characteristics of the Paleocene/Eocene Sediments corresponding to the PETM Biospheric Event in the Eastern Crimea (Nasypnoe Section)

18. Sedimentary environments and geochemistry of Upper Eocene and Lower Oligocene rocks in the northeastern Caucasus

19. Groundwater of the Pleistocene aquifer system in the North Caspian and Near-Caspian regions: Communication 2. Significance of sedimentary water integrity for the development of sedimentary basins and paleogeological reconstructions

20. Groundwater of the Pleistocene aquifer system in the north Caspian and near-Caspian regions: Communication 1. Character of water exchange and factors of sedimentary water integrity

21. [Conservative treatment of chronic diseases of lower limb veins: major risks of poor patient compliance]

22. [Efficacy of sulodexide in treatment of chronic venous insufficiency. Results of the ACCORD trial]

23. FEATURES OF HSP70-2 AND HSP70-НОМ GENE POLYMORPHISM IN THE PATIENTS WITH A HISTORY OF MYOCARDIAL INFARCTION

24. The late Cenomanian paleoecological event (OAE 2) in the eastern Caucasus basin of Northern Peri-Tethys

25. KOMPLEKSNYY ANALIZ KLINIChESKOY ZNAChIMOSTI VYYaVLENIYaALLEL'NYKh VARIANTOV GENOV TsITOKINOV IL1B, IL6, IL10, TNFA IFAKTORA ROSTA VEGF V KAChESTVE GENETIChESKIKh FAKTOROV RISKARAZVITIYa OSTEOPOROZA PRI SAKhARNOM DIABETE 2 TIPA

26. Frequencies of the DRB1, DQA1, DQB1 and TNFA alleles in immigrant population of west Siberia

27. [Peculiarities of treatment of chronic venous diseases in Russia. Preliminary results of the 'VEIN ACT Program']

28. Electrical muscle stimulation with Veinoplus® device in the treatment of venous ulcers

29. [Chronic venous oedema (C3 according to CEAP): new international guidelines and consensuses]

30. [Bioflavonoids and their significance in angiology: focus on diosmin]

31. [On advisability of perioperative phleboprotection in endovascular treatment of lower in varicose disease: first initial results of the decision study]

32. Electromuscular stimulation with VEINOPLUS® for the treatment of chronic venous edema

33. [Participation of leucocytes in pathogenesis of primary forms of lower limb chronic venous disease]

34. [Pharmacogenetic criteria for the efficacy of basic anti-inflammatory therapy for rheumatoid arthritis]

35. [Distribution of allelic variants of promotor sites of cytokine genes and endothelial growth factor gene among healthy subjects and patients with rheumatoid arthritis in a Russian Europeoid population]

36. [Analysis of the gene polymorphism of matrix metalloproteinase-2 and -9 in patients with coronary heart disease]

37. [Analysis of polymorphism of three positions of promoter region of TNF- gene in patients with ischemic heart disease, unstable angina and myocardial infarction]

38. [Frequencies of the DRB1, DQA1, DQB1 and TNFA alleles in immigrant population of West Siberia]

39. [Semisynthetic Diosmin (Phlebodia 600) for therapy of lower limb chronic venous insufficiency]

40. Chronic diseases of lower extremity veins in industrial workers of Moscow (results of the epidemiological survey)

41. [Study of the most often encountered allele of the HLA-B27 gene in Tuvinian and Russian inhabitants of Western Siberia]

42. [The use of internal controls of different lengths in the detection of Chlamydia trachomatis DNA by the polymerase chain reaction method]

43. [Association of TAP1/TAP2 gene polymorphism with inflammatory urogenital diseases combined with joint diseases]

44. POSSIBILITIES OF USING THE GENOTYPING OF CYTOKINES WITH INFLAMMATION-REGULATORY ACTIVITY AS BIOLOGICAL MARKERS FOR PREDICTION OF THE EFFICIENCY OF THERAPY FOR RHEUMATOID ARTHRITIS

Catalog

Books, media, physical & digital resources